C. Angerstein

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

M. Béhé, F. Raue, T. Behr, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

M. Béhé, M. Gotthardt, T. Behr, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.

R. Mach, M. Béhé, M. Stiehler, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Therapeutic advantages of Auger electron- over β-emitting radiometals or radioiodine when conjugated to internalizing antibodies

M. Béhé, G. Sgouros, T. Behr, 2000, European Journal of Nuclear Medicine.

Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate

S. Nilsson, M. Béhé, T. Behr, 2001, Medical oncology.

99mTc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model

O. Boerman, M. Béhé, O. Boerman, 2001, Nuclear medicine communications.

Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.

M. Béhé, D. Goldenberg, C. Apostolidis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retracted: Radioimmunotherapy of small‐volume disease of metastatic colorectal cancer

M. Béhé, D. Goldenberg, H. Becker, 2002, Cancer.

Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.

W. Hiddemann, A. Fayyazi, B. Wörmann, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retraction: “Radioimmunotherapy of small‐volume disease of metastatic colorectal cancer: Results of a phase II trial with the iodine‐131–labeled humanized anti–carcinoembryonic antigen antibody hMN‐14,”

M. Béhé, D. Goldenberg, H. Becker, 2002 .